Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13, Hsp70 interacting protein pseudogene 7 (ST13P7), also referred to as FAM10A7P, is classified as a pseudogene and is not thought to encode a functional protein product[3][7]. It is related by sequence to the functional ST13 gene, which encodes Hsp70 interacting protein (HIP), a co-chaperone involved in protein folding and regulation with potential roles in cancer and neurodegenerative diseases[4][5]; however, ST13P7 itself does not produce a functional protein and has no established direct biological or disease relevance. Thus, ST13P7 is not a therapeutic target, nor does it play a validated role in human physiology or pathology as a gene product[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (Hsp70 interacting protein) pseudogene 7 (ST13P7).